← Evidence map

ReviewExploration (Beijing, China)2023

Mesoporous silica/organosilica nanoparticles for cancer immunotherapy.

Shevanuja Theivendran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

32 papers cite it

2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 37933387